Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STOP MRSA: Antibiotic Strategies for SSTI
NCT00729937Phase 3Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Apr 2009
- Primary completion
- May 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of trimethoprim + sulfamethoxazole in skin and soft tissue infection (SSTI), sponsored by National Institute of Allergy and Infectious Diseases. Started Apr 2009; status: completed.
02
Drugs
trimethoprim + sulfamethoxazole
03
Conditions
skin and soft tissue infection (SSTI)
Beyond the preview
Go deeper on NCT00729937.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00729937.